Who Owns the AI Decision?

Healthcare AI governance is not just about whether the technology works.

It is about who remains accountable when it does not.

A clinical AI tool flags a patient as low risk.

A clinician accepts the recommendation.

The patient deteriorates.

An algorithm predicts demand incorrectly, contributing to staffing shortages. A financial model recommends a course of action that damages a service line’s performance.

In each case, the organization may ask whether the technology worked as intended. But a more consequential question comes first:

Who was accountable for the decision—and who had the authority to intervene?

As healthcare organizations adopt AI for clinical support, patient engagement, operations and financial planning, responsibility can become distributed across clinicians, executives, technology teams and external vendors. Everyone may have contributed to the decision, yet no one may have clear ownership of its consequences.

That is not simply a technology problem. It is a leadership design problem.

The Accountability Gap

AI can make recommendations, identify patterns and automate tasks. It cannot, by itself, establish who within an organization has the authority to accept a risk, override a recommendation or stop a system from operating.

Consider the common assumption that a clinician remains responsible whenever AI informs a clinical decision. In principle, human oversight sounds reassuring. In practice, can that clinician realistically challenge a recommendation if the system is difficult to interpret, the workflow discourages overrides or the organization has not provided clear escalation procedures?

Assigning responsibility without giving someone the information, authority and time to exercise it is accountability in name only.

The same problem appears outside clinical care. If an AI-generated forecast informs staffing, procurement or investment decisions, who validates the assumptions? Who challenges an implausible output? Who is responsible when leaders act on flawed information?

A named owner is necessary. An empowered owner is essential.

The Vendor Cannot Own the Whole Risk

Healthcare organizations may depend on technology vendors for model development, maintenance, updates and technical support. Contracts can allocate obligations, but outsourcing technology does not eliminate the healthcare provider’s responsibility to govern how it is used in its own setting.

A model that performs well in one population or workflow may be less reliable in another. Performance can change as patient populations, clinical practices, data quality or operational conditions change.

The overlooked risk is not only that an algorithm may be wrong. It is that the organization may have no reliable way to detect when it has become wrong.

Leaders should therefore ask what evidence supports the model’s use, which populations and situations fall outside its intended scope, how performance is monitored, and what happens when the system fails or becomes unavailable.

These are governance questions—not technical details to be delegated and forgotten.

Build Accountability Before the Incident

Effective healthcare AI governance begins before deployment.

For every consequential use case, leaders should establish:

• Decision ownership: Who is accountable for approving the use and its intended purpose?

• Human authority: Who can challenge, override or suspend an AI-supported decision?

• Escalation pathways: What triggers review, and who responds when performance or safety concerns emerge?

• Ongoing assurance: Who monitors errors, unexpected outcomes, bias, changes in performance and vendor updates?

• Incident learning: How will the organization investigate problems, communicate appropriately and prevent recurrence?

Not every AI application requires the same level of control. A tool that drafts routine administrative text does not carry the same risk as one that influences diagnosis, treatment or access to care. Governance should be proportionate to the consequences of error.

For UAE healthcare leaders, this also means ensuring that AI governance aligns with applicable local requirements, clinical accountability arrangements, privacy obligations and organizational policies. A global framework can guide the design, but it cannot replace local legal and regulatory review.

The Competitive Advantage of Clear Accountability

Organizations that clarify accountability early are better positioned to adopt useful AI without allowing responsibility to disappear between departments or suppliers.

They can make decisions faster because escalation routes are known. They can respond more coherently when something goes wrong. And they can build trust by demonstrating that innovation is accompanied by oversight—not simply enthusiasm.

The goal is not to eliminate every AI error. No system can guarantee that. The goal is to ensure that risks are anticipated, decisions have accountable owners, and problems can be identified and addressed before they escalate.

If an AI-supported decision causes harm or financial loss, can your organization identify who had the authority—and responsibility—to act?

At Phoenix MedStrategy, we help healthcare organizations strengthen the leadership systems, governance and decision accountability needed to adopt change responsibly and sustain competitive advantage.

Sources

World Health Organization. Ethics and Governance of Artificial Intelligence for Health: WHO Guidance. 2021.

World Health Organization. Regulatory Considerations on Artificial Intelligence for Health. 2023.

National Institute of Standards and Technology. Artificial Intelligence Risk Management Framework (AI RMF 1.0). 2023.

U.S. Food and Drug Administration, Health Canada, and Medicines and Healthcare products Regulatory Agency. Good Machine Learning Practice for Medical Device Development: Guiding Principles. 2021.